Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Obeticholic Acid: Designing Better FXR Assays
2026-09-01
Obeticholic Acid is a selective FXR agonist for mechanistic studies of bile acid homeostasis, cholestasis, and liver fibrosis. This article presents an assay-centered framework that connects FXR gene regulation with the Notch and NK-cell findings reported in recent fibrosis research without conflating distinct mechanisms.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-08-31
Yin et al. identify a brain-to-spinal opioid circuit that links repeated morphine exposure to mechanical hypersensitivity and analgesic tolerance in mice. The study separates mechanical pain adaptations from thermal effects and provides a circuit-level framework for opioid receptor signaling research and chronic pain research.
-
Sodium-Driven Mitochondrial Failure in NECSO
2026-08-31
Qiao and colleagues show that TRPM4-mediated sodium influx drives NECSO by disrupting mitochondrial ion handling, oxidative phosphorylation, and the TCA cycle rather than acting only through plasma-membrane ion imbalance. The work establishes a mechanistic connection between sodium overload, ATP failure, Na/K-ATPase collapse, cellular swelling, and necrotic lysis, providing a framework for targeted mitochondrial function analysis.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-08-30
Oh et al. developed and validated a scalable human iPSC-derived sensory neuron system that supports HSV-1 latency and experimentally induced reactivation. The model combines neuronal function with virological and chromatin-based latency criteria, providing a more human-relevant platform for studying neuron-intrinsic mechanisms and antiviral strategies.
-
Toremifene in Breast Cancer: 20 Years of Evidence
2026-08-29
This review examines two decades of clinical and pharmacologic evidence for toremifene, a selective estrogen receptor modulator used in estrogen receptor-positive breast cancer. Its main contribution is to place efficacy, metabolism, tissue-selective effects, and safety in a personalized-treatment framework rather than presenting toremifene as uniformly superior to tamoxifen or aromatase inhibitors.
-
7-Ethyl-10-hydroxycamptothecin in Translation
2026-08-28
A translational framework for using 7-Ethyl-10-hydroxycamptothecin (SN-38) to connect topoisomerase I inhibition, replication-associated damage, apoptosis, cell-cycle control, and FUBP1 biology in advanced colon cancer research.
-
Artesunate Workflows for Cancer Research
2026-08-28
Artesunate enables a more informative cancer-response workflow by separating growth suppression from actual cell killing. This guide translates its ferroptosis- and AKT/mTOR-relevant biology into practical dosing, time-course, assay-selection, and troubleshooting strategies for reproducible in vitro studies.
-
Relative vs Fractional Viability in Cancer Drug Testing
2026-08-27
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. By separating proliferative arrest from actual cell killing and considering their different timing, the study provides a more interpretable framework for in vitro cancer pharmacology.
-
Molidustat (BAY85-3934): HIF-PH Evidence
2026-08-27
Molidustat, also called BAY85-3934, is a HIF prolyl hydroxylase inhibitor that stabilizes hypoxia-inducible factors and supports endogenous erythropoietin stimulation. Its reported biochemical activity, CKD-anemia model results, formulation properties, and mechanistic limits are summarized with linked evidence.
-
0.4% Trypan Blue Solution: Practical Cell Counting
2026-08-26
0.4% Trypan Blue Solution provides a direct membrane-integrity readout for cell viability measurement, routine cell counting, and cytotoxicity assay workflows. It is intended for scientific research only and should not be used for diagnostic, clinical, or medical decisions.
-
GSK621: AMPK Agonist Workflows for AML and Immunometabolism
2026-08-26
GSK621 is a practical AMPK agonist for connecting energy sensing with AML viability, autophagy, lipid metabolism, and macrophage-state assays. This guide translates the 2024 Immunity discovery on lysosomal 25-hydroxycholesterol into controlled experiments that distinguish AMPK sufficiency from upstream lipid-signaling effects.
-
Diethylmaleate for Redox and GST Research
2026-08-25
Diethylmaleate is a small-molecule GSH-depletion tool for oxidative stress, redox regulation, and toxicology research. In a 2024 insect study, diethyl maleate inhibited GST activity by 64.05% and increased lambda-cyhalothrin sensitivity 7.91-fold under the reported experimental conditions.
-
Pyridostigmine, α7 nAChR, and Placental Necroptosis
2026-08-25
The reference study identifies placental necroptosis as a modifiable component of preeclampsia-like pathology and shows that pyridostigmine improves ischemia-associated outcomes through α7 nicotinic acetylcholine receptor signaling. Pharmacological blockade with α-bungarotoxin and comparison with necrostatin-1 provide a useful framework for separating cholinergic receptor dependence from general necroptosis inhibition.
-
GST-Driven Lambda-Cyhalothrin Resistance in M. usitatus
2026-08-24
Dong et al. show that MuGSTs1-mediated glutathione S-transferase activity helps Megalurothrips usitatus withstand lambda-cyhalothrin by reinforcing antioxidant defenses. Pharmacological GST inhibition with diethyl maleate reduced antioxidant capacity and sharply increased insecticide sensitivity, providing causal evidence that redox protection contributes to resistance.
-
TaqI Restriction Endonuclease Protocol Guide
2026-08-24
TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the TCG A recognition site. This guide covers setup, gel-based QC, and troubleshooting while defining the limits of the available product evidence; the enzyme is for scientific research use only, not diagnostic or medical applications.